| （単位：十億ドル） | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - |
| 研究開発費 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 営業費用 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 営業利益 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| 営業利益率 (%) | - | - | - | - | - | - | - | - | - | - | - | |||
| 純利益 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| 純利益率（％） | - | - | - | - | - | - | - | - | - | - | - | |||
| 一株あたり利益 | - | - | - | - | - | - | - | - | - | - | - | -0.4 | -2.66 | -1.59 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | - | - | - | - | - | -0.4 | -2.66 | -1.59 |